DE2828352C3 - Agents for treating seborrheic conditions - Google Patents

Agents for treating seborrheic conditions

Info

Publication number
DE2828352C3
DE2828352C3 DE2828352A DE2828352A DE2828352C3 DE 2828352 C3 DE2828352 C3 DE 2828352C3 DE 2828352 A DE2828352 A DE 2828352A DE 2828352 A DE2828352 A DE 2828352A DE 2828352 C3 DE2828352 C3 DE 2828352C3
Authority
DE
Germany
Prior art keywords
treatment
seborrheic
seborrheic conditions
conditions
capric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2828352A
Other languages
German (de)
Other versions
DE2828352B2 (en
DE2828352A1 (en
Inventor
Theodor Prof. Dr. Eckert
Fritz H. Prof. Dr. Kemper
Siegfried Prof. Dr. 4400 Muenster Nolting
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr August Wolff GmbH and Co KG Arzneimittel
Original Assignee
Dr August Wolff GmbH and Co KG Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr August Wolff GmbH and Co KG Arzneimittel filed Critical Dr August Wolff GmbH and Co KG Arzneimittel
Priority to DE2828352A priority Critical patent/DE2828352C3/en
Priority to AT0419279A priority patent/AT365450B/en
Priority to NL7904776A priority patent/NL7904776A/en
Priority to GB7921890A priority patent/GB2024010B/en
Priority to CA000330577A priority patent/CA1142854A/en
Priority to CS794393A priority patent/CS275816B6/en
Priority to SE7905659A priority patent/SE7905659L/en
Priority to IT12655/79A priority patent/IT1124116B/en
Priority to CH602279A priority patent/CH641042A5/en
Priority to FR7917398A priority patent/FR2437210A1/en
Priority to DK271279A priority patent/DK153738C/en
Priority to LU81429A priority patent/LU81429A1/en
Priority to JP8084179A priority patent/JPS559069A/en
Priority to BE0/196029A priority patent/BE877351A/en
Publication of DE2828352A1 publication Critical patent/DE2828352A1/en
Publication of DE2828352B2 publication Critical patent/DE2828352B2/en
Application granted granted Critical
Publication of DE2828352C3 publication Critical patent/DE2828352C3/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/008Preparations for oily skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Claims (1)

Patentanspruch:Claim: Verwendung von Caprin- bzw. Laurinsäure in einem alkoholischen Lösungsmittel bei der Behandlung seborrhoischer Zustände.Use of capric or lauric acid in an alcoholic solvent in the treatment seborrheic conditions. Die Erfindung befaßt sich mit der Behandlung seborrhoischer Zustände. Nachdem die früher übliche Behandlung seborrhoischer Zustände mit Salicylschwefel- und Teerpräparaten im Hinblick auf die allenfalls befriedigenden Behandlungsergebnisse und die unangenehme Anwendungsweise derartiger Präparate durch die Behandlung mit Cortison in Form alkoholischer Lösungen, entweder als Milch oder als Creme, ersetzt worden ist, hat es sich gezeigt, daß durch eine derartige Cortisonbehandlung zwar relativ schnell gute Anfangserfolge zu erzielen sind, andererseits aber auch nach längerer Anwendung häufig eine dauerhafte Besserung nicht zu erzielen ist, nach Absetzen der Behandlung also der alte seborrhoische Zustand mehr oder weniger schnell wiederkehrt Die Anwendung von Cortison über eine lange Zeitdauer ist jedoch im Hinblick auf die bekannten Cortinsonfolge- und -nebenwirkungen äußerst problematisch.The invention is concerned with the treatment of seborrheic conditions. After the usual Treatment of seborrheic conditions with salicylic sulfur and tar preparations with a view to the possible satisfactory treatment results and the unpleasant use of such preparations replaces treatment with cortisone in the form of alcoholic solutions, either as milk or as a cream has been, it has been shown that such a cortisone treatment gives good initial successes relatively quickly can be achieved, but on the other hand often a permanent improvement even after prolonged use cannot be achieved, i.e. the old seborrheic condition more or less after discontinuation of treatment Recurring quickly The use of cortisone over a long period of time is, however, in view of that known sequelae and side effects of cortinsonism are extremely problematic. Es ist andererseits aus DMW, Seite 20 bis 25 (1973) sowie »Ehrhardt-Reischig: Arzneimittel, Weinheim 1972, Seite 290« bekannt, mittelkettige Fettsäuren, insbesondere auch die acht Kohlenstoffatome aufweisende Caprylsäure therapeutisch zu verwenden, und zwar gegen Pilzinfektionen. Als topische Präparate sind dem Fachmann ferner alkoholische Lösungen allgemein bekannt Pilzinfektionen liegen in ihren Ursachen und in den Erfordernissen ihrer wirksamen Bekämpfung den krankhaften seborrhoischen Zuständen fern.On the other hand, it is from DMW, pages 20 to 25 (1973) and »Ehrhardt-Reischig: Arzneimittel, Weinheim 1972, page 290 «known medium-chain fatty acids, especially those containing eight carbon atoms To use caprylic acid therapeutically, namely against fungal infections. As topical preparations are Furthermore, alcoholic solutions are generally known to the person skilled in the art. Fungal infections lie in their causes and in far from the requirements of their effective control of the pathological seborrheic conditions. Der vorliegenden Erfindung liegt die Aufgabe zugrunde, die Möglichkeit zu einer hochv. irksamen, auch bei längerer Anwendung nebenerscheinigungsfreien Behandlung seborrhoischer Zustände aufzuzeigen.The present invention is based on the object of providing the possibility of a hochv. effective, to show treatment of seborrheic conditions free of side effects even after prolonged use. Die erfindungsgemäße Lösung besteht in der Verwendung von Caprin- bzw. Laurinsäuren in einemThe solution according to the invention consists in the use of capric or lauric acids in one alkoholischen Lösungsmittel eben bei der Behandlung derartiger seborrhoischer Zustände.alcoholic solvents in the treatment of such seborrheic conditions. Es hat sich überraschend bei der Anwendung von Caprinsäure und Laurinsäure, also mittelkettiger Fettsäuren mit zehn bzw. zwölf Kohlenstoffatomen in alkoholischer Lösung als Befund gezeigt, daß schon innerhalb der ersten sieben bis zehn Tage nach zunächst milder Rötung der Haut und vermehrter Abschuppungstätigkeit die Haut umgehend einen völlig normalen Verhornungsvorgang aufzeigte. Der längerfristige Befund hat aufgezeigt, daß Anzeichen von Entzündungen und vermehrter Schuppenbildung auch dann nicht mehr auftraten, wenn die Anwendung nicht mehl ganz regelmäßig eingesetzt wurde. Pausen von mehreren Tagen konnten unbedenklich eingeschaltet werden. Auch der oft quälende Juckreiz war nach kurzer Zeit verschwunden. Wesentlich ist, daß auch nach langfristiger Anwendung Unverträglichkeiten oder irgendwelche allergischen Reaktionen in keinem einzigen Fall zu verzeichnen waren, so daß eine langfristige Behandlung schwerer Fälle gewährleistet erscheintIt has been found surprising when using capric acid and lauric acid, i.e. medium-chain fatty acids with ten or twelve carbon atoms in alcoholic solution as a finding showed that already within the first seven to ten days after initially mild reddening of the skin and increased peeling activity the skin immediately showed a completely normal cornification process. The longer term Findings have shown that even then there are no signs of inflammation and increased flaking occurred more if the application was not used very regularly. Breaks from several Days could be switched on without hesitation. The often excruciating itching also subsided after a short time disappeared. It is essential that even after long-term use, intolerance or any allergic reactions were not recorded in a single case, so long-term treatment more severe cases appear guaranteed Nachfolgend werden Beispiele für die Verwendung angegeben:Examples of its use are given below: Beispiel 1example 1 Zur Behandlung seborrhoischer Zustände wird Caprinsäure in einer Konzentration von 5% in 96%igem Äthylalkohol gelöst verwendet.For the treatment of seborrheic conditions, capric acid is used at a concentration of 5% in 96% ethyl alcohol dissolved used. Beispiel 2Example 2 Zur Behandlung seborrhoischer Zustände wird Laurinsäure in einer Konzentration von 5% in Isopropylalkohol gelöst verwendetFor the treatment of seborrheic conditions, lauric acid is used at a concentration of 5% in Dissolved isopropyl alcohol is used Beispiel 3Example 3 Zur Behandlung seborrhoischer Zustände wird Caprinsäure in einer Konzentration von 5% in Propylenglj kol gelöst verwendet.For the treatment of seborrheic conditions, capric acid is used at a concentration of 5% in Propylenglj kol used dissolved. Beispiel 4Example 4 Zur Behandlung seborrhoischer Zustände wird Caprinsäure in einer Konzentration von 10% in Polyäthylenglykol gelöst verwendet.For the treatment of seborrheic conditions, capric acid is used at a concentration of 10% in Polyethylene glycol used dissolved.
DE2828352A 1978-06-28 1978-06-28 Agents for treating seborrheic conditions Expired DE2828352C3 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DE2828352A DE2828352C3 (en) 1978-06-28 1978-06-28 Agents for treating seborrheic conditions
AT0419279A AT365450B (en) 1978-06-28 1979-06-12 METHOD FOR PRODUCING A TOPICAL AGENT
NL7904776A NL7904776A (en) 1978-06-28 1979-06-19 PREPARATION FOR TREATING SEBORRHOEA.
GB7921890A GB2024010B (en) 1978-06-28 1979-06-22 Compositions for containing fatty acids for the treatment of seborrhoeic conditions
CS794393A CS275816B6 (en) 1978-06-28 1979-06-26 Cosmetic preparation for use on greasy skin
CA000330577A CA1142854A (en) 1978-06-28 1979-06-26 Method and compositions for the treatment of seborrhea
IT12655/79A IT1124116B (en) 1978-06-28 1979-06-27 PREPARED FOR THE TREATMENT OF SEBORRHEIC DERMATITIS
CH602279A CH641042A5 (en) 1978-06-28 1979-06-27 MEANS OF TREATMENT OF SEBORRHOIC CONDITIONS.
SE7905659A SE7905659L (en) 1978-06-28 1979-06-27 MEANS FOR THE TREATMENT OF SEBORREIS CONDITIONS
FR7917398A FR2437210A1 (en) 1978-06-28 1979-06-27 COMPOSITION FOR THE TREATMENT OF SEBORRHEIC CONDITIONS
DK271279A DK153738C (en) 1978-06-28 1979-06-27 COSMETIC AGENT FOR TREATMENT OF SEBORRHOIC CONDITIONS
LU81429A LU81429A1 (en) 1978-06-28 1979-06-27 MEANS FOR TREATMENT OF SEBORRHOUS CONDITIONS
JP8084179A JPS559069A (en) 1978-06-28 1979-06-28 Seborrhea remedy
BE0/196029A BE877351A (en) 1978-06-28 1979-06-28 SEBORRHEA TREATMENT PRODUCTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2828352A DE2828352C3 (en) 1978-06-28 1978-06-28 Agents for treating seborrheic conditions

Publications (3)

Publication Number Publication Date
DE2828352A1 DE2828352A1 (en) 1980-01-17
DE2828352B2 DE2828352B2 (en) 1980-09-25
DE2828352C3 true DE2828352C3 (en) 1981-08-20

Family

ID=6043011

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2828352A Expired DE2828352C3 (en) 1978-06-28 1978-06-28 Agents for treating seborrheic conditions

Country Status (14)

Country Link
JP (1) JPS559069A (en)
AT (1) AT365450B (en)
BE (1) BE877351A (en)
CA (1) CA1142854A (en)
CH (1) CH641042A5 (en)
CS (1) CS275816B6 (en)
DE (1) DE2828352C3 (en)
DK (1) DK153738C (en)
FR (1) FR2437210A1 (en)
GB (1) GB2024010B (en)
IT (1) IT1124116B (en)
LU (1) LU81429A1 (en)
NL (1) NL7904776A (en)
SE (1) SE7905659L (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2912438A1 (en) * 1979-03-29 1980-10-16 Eckert Theodor Topical treatment of skin diseases - with alcoholic soln. of fatty acid
US4406884A (en) * 1981-06-23 1983-09-27 The Procter & Gamble Company Topical antimicrobial composition
EP0116439A3 (en) * 1983-02-02 1986-01-29 Suntory Limited Fatty acid containing hair tonic composition
JPS59175425A (en) * 1983-03-25 1984-10-04 Otsuka Pharmaceut Co Ltd Vessel strengthening agent
DE3603595A1 (en) * 1986-02-06 1987-08-13 Beiersdorf Ag HAIR COSMETIC AGENTS
DE4229737C2 (en) * 1992-09-05 1996-04-25 Beiersdorf Ag Deodorizing cosmetic products containing fatty acids
EP0702950A1 (en) * 1994-09-26 1996-03-27 Beiersdorf Aktiengesellschaft Use of fatty acids against skin superinfections
FR2752421B1 (en) * 1996-08-13 2001-05-04 Fabre Pierre Dermo Cosmetique SALTS OF ANTI-SEBORRHEIC GUANIDINES
US20070142255A1 (en) * 2005-12-16 2007-06-21 Conopco, Inc., D/B/A Unilever Skin benefit composition and a method for using the same
JP5850453B2 (en) * 2012-01-04 2016-02-03 洋一 赤間 External skin analgesics, skin puncture pain relievers and subcutaneous vein vasodilators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR46241E (en) * 1935-04-03 1936-04-02 Ig Farbenindustrie Ag Cosmetic product
GB801726A (en) * 1956-01-25 1958-09-17 Havva Rabinovitch Improvements in or relating to pharmaceutical preparations
GB1137125A (en) * 1965-12-08 1968-12-18 Unilever Ltd Improved soap products

Also Published As

Publication number Publication date
GB2024010A (en) 1980-01-09
DK153738B (en) 1988-08-29
ATA419279A (en) 1981-06-15
DK153738C (en) 1989-01-09
DE2828352B2 (en) 1980-09-25
SE7905659L (en) 1979-12-29
FR2437210B1 (en) 1983-02-18
AT365450B (en) 1982-01-11
DK271279A (en) 1979-12-29
CH641042A5 (en) 1984-02-15
BE877351A (en) 1979-10-15
IT7912655A0 (en) 1979-06-27
CS439379A3 (en) 1992-03-18
CS275816B6 (en) 1992-03-18
NL7904776A (en) 1980-01-03
DE2828352A1 (en) 1980-01-17
GB2024010B (en) 1982-11-10
FR2437210A1 (en) 1980-04-25
IT1124116B (en) 1986-05-07
JPS559069A (en) 1980-01-22
CA1142854A (en) 1983-03-15
LU81429A1 (en) 1979-10-30

Similar Documents

Publication Publication Date Title
DE2802924C2 (en) Medicines to treat acne
DE3032462C2 (en)
EP0892635B1 (en) Cosmetic preparations containing extracts from phyllantus emblica and centella asiatica and/or bacopa monnieri
DE2046119C2 (en) Means for treating acne
DE4100975A1 (en) Cosmetic or pharmaceutical preparations for improving hair quality and promoting hair growth
DE3402880A1 (en) OIL-IN-WATER CREAM AND METHOD FOR THEIR PRODUCTION
DE2947742A1 (en) (BETA) -CYCLODEXTRIN AS AN ANTI-ACNE AGENT
DE2828352C3 (en) Agents for treating seborrheic conditions
DE2601489C2 (en)
DE1804801C3 (en) Acne treatment agents
EP0325628B1 (en) Agent containing salicylic acid for treating lepidosis
DE2145204A1 (en) Hair tonic - contg detergent base, nutrient and growth stimulant
DE3211913A1 (en) Composition for promoting hair growth and for reducing dandruff
EP0432354B1 (en) Bath additive and its use
DE2912438A1 (en) Topical treatment of skin diseases - with alcoholic soln. of fatty acid
DE4433666A1 (en) An agent for the treatment or care of irritated or inflamed skin comprising an extract of dried or fresh ribwort plantain (Plantago lanceolata L.) in a base which allows application on the skin as a stick, roller or cream
DE4119170C2 (en) Remedies for atopic dermatitis
DE202007004981U1 (en) Composition, in particular for the topical treatment of skin diseases
DE4110134A1 (en) Cosmetic and/or pharmaceutical compsn. contg. banana skin - for external application to skin, esp. to treat warts and other skin disorders
DE2934090A1 (en) Agent for treating hyper:keratotic skin diseases - contains undecylenic acid pref. in combination with ascorbic acid
DE19821971A1 (en) Composition for treating psoriasis or neurodermatitis
DE2715214C2 (en) Hair lotion
DE19736265C2 (en) Medicines for the treatment of skin diseases
DE19954040A1 (en) Use of phenol derivatives, e.g. thymol, as prostaglandin antagonists and antiproliferative agents for treating tumors
DE3123943A1 (en) "HAIR TREATMENT AGENT"

Legal Events

Date Code Title Description
OAP Request for examination filed
OD Request for examination
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee